表紙
市場調查報告書

緩釋性注射劑

Sustained Release Injectables to 2026

出版商 Greystone Research Associates 商品編碼 672887
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
緩釋性注射劑 Sustained Release Injectables to 2026
出版日期: 2019年08月06日內容資訊: 英文
簡介

本報告提供緩釋性注射劑調查分析,上市產品,製劑技術,需求促進因素,市場潛在性與課題,治療藥市場區隔,市場影響要素等系統性資訊。

摘要整理

注射劑市場趨勢

  • 自我給藥趨勢
  • 注射劑的製劑技術
  • 注射用設備設計的創新
  • 治療的需求促進因素
  • 市場要素
  • 競爭情形
  • 危險因素

緩釋性製劑技術

  • 生物分解性高分子
  • SR製劑技術品牌化
  • 物理的流程的管理方法

緩釋性注射劑 - 開發要素

  • 製劑要素
  • 穩定性
  • 冷凍乾燥
  • 包裝
  • 給藥要素

緩釋性產品情勢

  • 生物鹼
  • 麻醉劑
  • 抗癌藥物
  • GnRH受體激動劑
  • 類鴉片物質拮抗劑
  • 合成肽
  • 細胞激素
  • 荷爾蒙
  • 抗精神病藥
  • 其他

開發階段的SR注射劑

SR注射劑 - 治療藥市場部門分析與預測

  • 依賴
  • 內分泌學
  • 血糖管理
  • 感染疾病
  • 荷爾蒙缺乏症
  • 代謝疾病
  • 神經學
  • 腫瘤學
  • 白血病
  • 淋巴瘤
  • 前列腺
  • 疼痛管理
  • 生殖健康

企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SJB982

Currently approved sustained release injectables rely on a spectrum of branded formulation technologies to modulate the drug's release profile post-injection. Typically off-patent or generic drugs, they include drug therapies for almost a dozen major therapeutic segments, including neurological conditions, metabolic diseases, oncology, pain management and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population, the attraction and interest in sustained release injectables will increase.

Sustained Release Injectables - What You Will Learn

  • What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
  • What are the major factors driving sustained release injectable drug demand?
  • What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
  • How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
  • What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
  • In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
  • What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Trend toward Self-Administration
  • Injectable Drug Formulation Technology
  • Innovation in Injectable Device Designs
  • Therapeutic Demand Drivers
  • Market Factors
  • Competitive Landscape
  • Risk Factors

Sustained Release Formulation Technologies

  • Biodegradable Polymers
  • Branded SR Formulation Technologies
  • Physical Process Control Methods

Sustained Release Injectables - Development Factors

  • Formulation Factors
  • Stability
  • Lyophilization
  • Packaging
  • Administration Factors

The Sustained Release Product Landscape

  • Alkaloids
  • Anesthetics
  • Antineoplastics
  • GnRH Agonists
  • Opioid Antagonists
  • Synthetic Peptides
  • Cytokines
  • Hormones
  • Antipsychotics
  • Other Drug Classes

Development-stage SR Injectables

SR Injectables - Therapeutic Market Sector Analysis & Forecasts

  • Addiction
  • Endocrinology
  • Glycemic Control
  • Infectious Disease
  • Hormone Deficiency
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Leukemia
  • Lymphoma
  • Prostate
  • Pain Management
  • Reproductive Health

Company Profiles

Back to Top